documents: FDA-1982-N-0005-0074
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1982-N-0005-0074 | FDA | FDA-1982-N-0005 | Attachment 5. "Double-Blind, Single Dose Evaluation of the Relavite analgesic Efficacy and Adverse Effect Liability of Effervescent Aspirin, Non-Effervescent Aspirin and Placebo in the Treatment of Postoperative Pain Following Oral Surgery." re Request for Hearing form Miles, Inc. | Supporting & Related Material | Background Material | 2016-10-13T04:00:00Z | 2016 | 10 | 2016-10-13T20:25:33Z | 0 | 0 | 090000648050d722 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref